Literature DB >> 6727282

[Temperature-dependent spontaneous platelet aggregation in polycythemia vera and primary thrombocythemia: a diagnostic criterion].

P Fröhli, R Streuli, K Rhyner.   

Abstract

In twenty patients suffering from myeloproliferative syndromes (nine with polycythaemia vera, 11 with primary thrombocythaemia) platelet aggregation was tested following incubation of blood samples at 4 degrees C, room temperature, 30 degrees C and 37 degrees C. A spontaneous platelet aggregation following incubation at room temperature took place in 65% of patients with primary thrombocythaemia. At the two higher temperatures, positive results were seen in 72% and 92% of cases, respectively. Seven of nine patients (78%) showed a pathological spontaneous platelet aggregation at room temperature. Pathological spontaneous platelet aggregation at 30 degrees C occurred in eight of nine (89%) cases. The spontaneous platelet aggregation test is a simple method to diagnose primary thrombocythaemia and asymptomatic polycythaemia vera, the sensitivity of which increases considerably following incubation of blood samples at two and three different temperatures.

Entities:  

Mesh:

Year:  1984        PMID: 6727282     DOI: 10.1007/BF01742298

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  23 in total

1.  Influence of time, temperature and platelet concentration on dog platelet aggregation.

Authors:  D J Brackett; C F Schaefer; C G Gunn
Journal:  Thromb Res       Date:  1976-04       Impact factor: 3.944

2.  Abnormalities of platelet function in patients with polycythemia vera.

Authors:  S Berger; L M Aledort; H S Gilbert; J P Hanson; L R Wasserman
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  Effect of temperature on ADP-induced platelet aggregation. Its significance in studying anti-aggregating drugs.

Authors:  C A Praga; E M Pogliani
Journal:  Thromb Diath Haemorrh       Date:  1973-02-28

4.  Time and temperature dependent changes of ADP - and collagen-induced and "spontaneous" aggregation.

Authors:  K Breddin; M Ziemen; O Bauer; W Herrmann; L Schaudinn; U Schlosser; A Winterhagen; H J Krzywanek
Journal:  Thromb Res       Date:  1980 Aug 15-Sep 1       Impact factor: 3.944

5.  Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders.

Authors:  J Nishimura; S Okamoto; H Ibayashi
Journal:  Thromb Haemost       Date:  1979-06-30       Impact factor: 5.249

6.  Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders.

Authors:  M Okuma; H Uchino
Journal:  Blood       Date:  1979-12       Impact factor: 22.113

7.  A comparison of methods for the study of platelet hyperfunction in thromboembolic disorders.

Authors:  Y C Chen; K K Wu
Journal:  Br J Haematol       Date:  1980-10       Impact factor: 6.998

8.  Myeloproliferative disorders: a paradox of in-vivo and in-vitro platelet function.

Authors:  B J Boughton; W E Corbett; A D Ginsburg
Journal:  J Clin Pathol       Date:  1977-03       Impact factor: 3.411

9.  Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.

Authors:  C Caranobe; P Sie; C Nouvel; G Laurent; J Pris; B Boneu
Journal:  Scand J Haematol       Date:  1980-10

10.  Platelet function in patients with high platelet counts.

Authors:  A D Ginsburg
Journal:  Ann Intern Med       Date:  1975-04       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.